First CAR-T Cell Therapy Conducted

Why in News ? Clinical trials of Chimeric Antigen Receptor T-cell (CAR-T) therapy were conducted globally. Therapy has emerged as a breakthrough in cancer treatment. It has shown promising results on end stage patients, especially in patients of Acute Lymphocytic Leukemia. About: CAR-T technology has a remarkable therapeutic potential for cancer patients. This technology is not available in India, currently. Background BIRAC and DBT have initiated and launched specialised calls and invitation to promote and support development of CAR-T cell technology against cancer and other diseases. What are the challenges? CAR-T cell therapy costs rupees 3-4 crore for each patient.....Read More